Epling BP, Rocco JM, Boswell KL, Laidlaw E, et al. Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment. Clin Infect Dis 2022 Oct 6. pii: 6749408. doi: 10.1093.
PMID: 36200701